Salbutamol

Salbutamol

Chemical structure of Salbutamol

Salbutamol, also known as albuterol in the United States, is a medication that is primarily used to treat asthma and chronic obstructive pulmonary disease (COPD). It is a short-acting β2 adrenergic receptor agonist that works by relaxing the muscles in the airways and increasing airflow to the lungs.

Medical Uses

Salbutamol is commonly used for the relief of bronchospasm in conditions such as asthma and COPD. It is often administered via an inhaler or nebulizer to provide quick relief from acute symptoms. The medication can also be used prophylactically to prevent exercise-induced bronchoconstriction.

Asthma

In the management of asthma, salbutamol is used as a "rescue" medication to relieve acute symptoms such as wheezing, coughing, and shortness of breath. It is not intended for long-term control of asthma, which typically requires the use of inhaled corticosteroids or other long-acting medications.

COPD

For patients with COPD, salbutamol helps to alleviate symptoms by relaxing the muscles around the airways, making it easier to breathe. It is often used in combination with other medications such as ipratropium for enhanced effect.

Mechanism of Action

Salbutamol works by stimulating β2 adrenergic receptors in the lungs, leading to the activation of adenylate cyclase and an increase in cyclic AMP levels. This results in the relaxation of bronchial smooth muscle and subsequent bronchodilation.

Side Effects

Common side effects of salbutamol include tremor, headache, tachycardia, and palpitations. These effects are generally mild and transient. In some cases, patients may experience hypokalemia or paradoxical bronchospasm.

Pharmacokinetics

Salbutamol is rapidly absorbed when inhaled, with effects typically occurring within minutes and lasting for 4 to 6 hours. It is metabolized in the liver and excreted primarily in the urine.

Chemistry

3D model of Salbutamol

Salbutamol is a racemic mixture consisting of equal parts of the (R)- and (S)-enantiomers. The (R)-enantiomer is responsible for the bronchodilatory effects, while the (S)-enantiomer is considered to be less active.

Enantiomers of Salbutamol

Formulations

Salbutamol is available in various formulations, including metered-dose inhalers (MDIs), dry powder inhalers (DPIs), and nebulizer solutions. It is also available in oral tablet and syrup forms, although these are less commonly used due to slower onset of action.

History

Salbutamol was first introduced in the 1960s and has since become one of the most widely used medications for the treatment of asthma and COPD. It was developed as an alternative to isoprenaline, which had significant cardiac side effects.

Related Pages

• Asthma
• Chronic obstructive pulmonary disease
• Bronchodilator
• Beta-2 adrenergic receptor

Ventolin tablets containing Salbutamol

See Also

• Ipratropium
• Inhaler
• Nebulizer

Medication used to treat asthma and COPD